These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14645491)

  • 1. Multiple molecular determinants for allosteric modulation of alternatively spliced AMPA receptors.
    Quirk JC; Nisenbaum ES
    J Neurosci; 2003 Nov; 23(34):10953-62. PubMed ID: 14645491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural determinants of allosteric regulation in alternatively spliced AMPA receptors.
    Partin KM; Bowie D; Mayer ML
    Neuron; 1995 Apr; 14(4):833-43. PubMed ID: 7718245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular determinants responsible for differences in desensitization kinetics of AMPA receptor splice variants.
    Quirk JC; Siuda ER; Nisenbaum ES
    J Neurosci; 2004 Dec; 24(50):11416-20. PubMed ID: 15601947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological detection of AMPA receptor heterogeneity by use of two allosteric potentiators in rat hippocampal cultures.
    Sekiguchi M; Takeo J; Harada T; Morimoto T; Kudo Y; Yamashita S; Kohsaka S; Wada K
    Br J Pharmacol; 1998 Apr; 123(7):1294-303. PubMed ID: 9579722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable expression of recombinant AMPA receptor subunits: binding affinities and effects of allosteric modulators.
    Hennegriff M; Arai A; Kessler M; Vanderklish P; Mutneja MS; Rogers G; Neve RL; Lynch G
    J Neurochem; 1997 Jun; 68(6):2424-34. PubMed ID: 9166736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative allosteric modulation of wild-type and mutant AMPA receptors by GYKI 53655.
    Partin KM; Mayer ML
    Mol Pharmacol; 1996 Jan; 49(1):142-8. PubMed ID: 8569699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate.
    Partin KM; Fleck MW; Mayer ML
    J Neurosci; 1996 Nov; 16(21):6634-47. PubMed ID: 8824304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro.
    Miu P; Jarvie KR; Radhakrishnan V; Gates MR; Ogden A; Ornstein PL; Zarrinmayeh H; Ho K; Peters D; Grabell J; Gupta A; Zimmerman DM; Bleakman D
    Neuropharmacology; 2001 Jun; 40(8):976-83. PubMed ID: 11406188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.
    Johansen TH; Chaudhary A; Verdoorn TA
    Mol Pharmacol; 1995 Nov; 48(5):946-55. PubMed ID: 7476926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LY404187: a novel positive allosteric modulator of AMPA receptors.
    Quirk JC; Nisenbaum ES
    CNS Drug Rev; 2002; 8(3):255-82. PubMed ID: 12353058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of desensitization at glutamate receptors in isolated crucian carp horizontal cells by concanavalin A, cyclothiazide, aniracetam and PEPA.
    Shen Y; Lu T; Yang XL
    Neuroscience; 1999 Mar; 89(3):979-90. PubMed ID: 10199629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of kinetic properties of GluR2 AMPA receptor channels by alternative splicing.
    Koike M; Tsukada S; Tsuzuki K; Kijima H; Ozawa S
    J Neurosci; 2000 Mar; 20(6):2166-74. PubMed ID: 10704491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines.
    Donevan SD; Rogawski MA
    Neuroscience; 1998 Dec; 87(3):615-29. PubMed ID: 9758228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single residue contributes sensitivity to allosteric modulation of AMPA receptors by LY395153.
    Quirk JC; Linden AM; Strakhova M; Yu H; Skolnick P; Nisenbaum ES
    Eur J Pharmacol; 2002 Nov; 454(2-3):125-9. PubMed ID: 12421639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A desensitization-selective potentiator of AMPA-type glutamate receptors.
    Sekiguchi M; Nishikawa K; Aoki S; Wada K
    Br J Pharmacol; 2002 Aug; 136(7):1033-41. PubMed ID: 12145103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential modulation of AMPA receptors by cyclothiazide in two types of striatal neurons.
    Vorobjev VS; Sharonova IN; Haas HL; Sergeeva OA
    Eur J Neurosci; 2000 Aug; 12(8):2871-80. PubMed ID: 10971630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flip and flop: a molecular determinant for AMPA receptor channel opening.
    Pei W; Huang Z; Wang C; Han Y; Park JS; Niu L
    Biochemistry; 2009 May; 48(17):3767-77. PubMed ID: 19275243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMPA receptor heterogeneity in rat hippocampal neurons revealed by differential sensitivity to cyclothiazide.
    Fleck MW; Bähring R; Patneau DK; Mayer ML
    J Neurophysiol; 1996 Jun; 75(6):2322-33. PubMed ID: 8793745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanism of flop selectivity and subsite recognition for an AMPA receptor allosteric modulator: structures of GluA2 and GluA3 in complexes with PEPA.
    Ahmed AH; Ptak CP; Oswald RE
    Biochemistry; 2010 Apr; 49(13):2843-50. PubMed ID: 20199107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants.
    Partin KM; Patneau DK; Mayer ML
    Mol Pharmacol; 1994 Jul; 46(1):129-38. PubMed ID: 8058047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.